Skip to main content
. 2024 Aug 24;25(17):9199. doi: 10.3390/ijms25179199

Table 7.

SFTI-1-based selective inhibitors.

Target Sequence Ki
Trypsin &1GRC(&2)TKSIPPIC(&2)FPD&1 (native SFTI-1) 100 pM [194]
Trypsin GRC(&)TKSIPAIC(&)FPD 1.7 pM [195]
Trypsin GKC(&)TKSIPPIC(&)FPD 2.0 pM [195]
Chymotrypsin GRC(&)TXSIPPIC(&)FPD (X = 4-fluoro-L-phenylalanine) 30.0 pM [196]
Matriptase KRC(&)TKSIPPRC(&)HPD (SDMI-3) 2.1 pM [197]
Plasmin &1GRC(&2)YKSKPPIC(&2)FPD&1 50.0 pM [198]
KLK-4 &1GFC(&2)QRSIPPIC(&2)FPN&1 40.0 pM [199]
KLK-5 &1GYC(&2)NRSYPPEC(&2)FPN&1 340 pM [200]
KLK-7 &1GKC(&2)LFSNPPIC(&2)FPN&1 140 pM [201]
Furin KRC(&)KKSIPPRC(&)F-NH2 490 pM [188]
Chymase &1GRC(&2)QXSEPPEC(&2)FPD&1 (X = 4-chloro-L-phenylalanine) 1.8 nM [202]
Cathepsin G &1GTC(&2)X1X2SDPPIC(&2)FPN&1 (X1 = norleucine; X2 = 4-guanidine-L-phenylalanine) 1.6 nM [203]